RxDoctor Payments Data

Joseph Bee, MD

Otolaryngology/Facial Plastic Surgery · Brunswick, GANPI 1942431408

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations.

$1,595in general payments, 2019–2025

Across 69 payments — averaging $23.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$364
  • Sanofi$295
  • Regeneron Healthcare Solutions, Inc.$286
  • GSK$218
  • Aerin Medical Inc.$113
  • Merck$74
  • plus $245 from 8 others

What the payments were for

  • Food & beverage$1,595100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,595 in reported general payments places this provider in the 65th percentile of 21 otolaryngology/facial plastic surgery providers in Georgia.

See all otolaryngology/facial plastic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$164,697
Medicare patients
708
Services billed
1,553

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Olopatadine Hcl105$9,254
Azelastine Hcl379$9,137
Fluticasone Propionate375$5,306
Famotidine287$2,482
Ipratropium Bromide59$2,357
Mometasone Furoate17$2,232
Tobramycin-DexamethasoneTobramycin/Dexamethasone39$2,110
Omeprazole282$2,003
Cefdinir85$1,772
Levocetirizine Dihydrochloride112$1,273
Fluocinolone Acetonide Oil26$1,144
Ofloxacin45$742
Methylprednisolone125$727
Ondansetron OdtOndansetron43$339
CefuroximeCefuroxime Axetil11$221

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Brunswick

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →